header image

Page 46«..1020..45464748..6070..»

Impact of preemptive therapy for Cytomegalovirus on …

Available online 5 July 2020

We evaluated the impact of CMV managed with preemptive therapy (PET) on healthcare resource utilization after hematopoietic cell transplantation (HCT) at a single center.

In multivariable models CMV managed by PET was associated increased number of readmissions and inpatient cost.

CMV-related readmissions were associated with increased length of stay (LOS) and cost compared to non CMV-related readmissions.

CMV viremia occurs in 40%-80% of CMV seropositive (R+) allogeneic hematopoietic stem cell (HCT) recipients. The preemptive therapy (PET) strategy has reduced the risk of CMV end-organ disease (EOD) and associated mortality but may lead to substantial healthcare resource utilization (HCRU) and cost. Real-world data on the economic impact of PET is relevant for the evaluation of alternative strategies for CMV management. We examined the impact of clinically significant CMV treated with PET on inpatient length of stay (LOS), number of readmissions and associated costs from day (D) 0 through D 180 post-HCT.

A retrospective study of CMV seropositive (R+) adults who underwent peripheral blood or marrow allogeneic HCT from March 2013 through December 2017 at Memorial Sloan Kettering Cancer Center. Patients were routinely screened for CMV by quantitative PCR and received PET per institutional standards of care. Data was extracted from electronic medical records and hospital databases. Itemized cost data per patient was obtained from the Vizient database adjusted to 2017 dollars using inflation indices. Study outcomes included healthcare resource use (HCRU) evaluated by inpatient LOS and inpatient cost in patients who received PET for clinically significant CMV (PET group) compared to those who did not receive PET (no PET group); and frequency and cost of CMV-related compared to non-CMV-related readmissions. We utilized multivariable negative binomial and log-linked Gamma models to examine the incremental healthcare resource use and cost associated with PET controlling for other potential factors.

Of 357 patients included in the analyses, PET was initiated in 208 (56.5%) at a median of 35 days after HCT. By D180, 23 patients (6.4%) developed CMV EOD and three (0.8%) died of CMV. PET recipients had a longer LOS for HCT admission (p=0.0276) and total LOS by D 180 (p=0.0001), higher number of readmissions (p=0.0001), higher mean inpatient cost for HCT admission ($189,389 vs. $151,646, p=0.0133) and total inpatient cost by D180 ($297,563 vs. $205,815, p<0.0001) compared with no PET recipients. Among PET recipients, CMV-related readmissions were associated with higher mean cost per episode compared to non CMV-related readmissions ($165,455 vs. $89,419, p=0.005). CMV-related readmissions comprised of 40.6% of total all-cause readmissions and incurred 55.9% of total all-cause readmission cost in PET recipients.

HCT recipients who had CMV infection treated with the currently available PET had a greater inpatient HCRU including LOS and cost by D 180 compared with patients who did not receive PET. The cost of CMV-related readmissions accounted for 60% of total readmission cost among PET recipients. Future studies are needed to examine the cost-effectiveness of alternative strategies for CMV management.

Hematopoietic cell transplantation (HCT)

cytomegalovirus (CMV)

preemptive therapy (PET)

readmission

healthcare resource utilization (HCRU)

inpatient cost

Recommended articlesCiting articles (0)

2020 Published by Elsevier Inc. on behalf of the American Society for Transplantation and Cellular Therapy

Go here to see the original:
Impact of preemptive therapy for Cytomegalovirus on ...

Global Animal Stem Cell Therapy Market Report 2020 By Key Players, Trends, Countries, Market Size, Forecast To 2024 (based On 2020 Covid-19 Worldwide…

The GlobalAnimal Stem Cell Therapy MarketResearch Report is a helpful source of insightful data for business strategists.It provides thedeep insights into the global market revenue, market segments, competitive landscape, manufacturing, and pricing and cost structures, growth factor. The industry overview is added after a widespread study of the significant business drivers, hindering factors and future industry prospect. Animal Stem Cell Therapy report studies the present state of the market to analyze the future opportunities and risks.

Get FREE Sample Copy (including COVID19 Impact Analysis, FULL TOC, Graphs, and Tables) of this report: https://www.globalmarketers.biz/report/life-sciences/global-animal-stem-cell-therapy-market-2019-by-manufacturers,-regions,-type-and-application,-forecast-to-2024/130268#request_sample

Animal Stem Cell Therapy Market Report Scope:

Due to COVID-19 crisis takes over the globe, we are constantly track the changes in the markets, as well as the industry behaviors of the customers worldwide and our estimate about the newest market trends and forecasts are being done after in view of the impact of this pandemic.

Get an Upto 30% Discount On Animal Stem Cell Therapy Market Report, Do Inquiry Here: https://www.globalmarketers.biz/discount_inquiry/discount/130268

Global Animal Stem Cell Therapy Market Segmentation:

By Type:

DogsHorsesOthers

By Application:

Veterinary HospitalsResearch Organizations

The Global Animal Stem Cell Therapy Market report includes the precisely studied and assessed statistics of the key vendor and their scope in the market utilizing several analytical tools. The Porters five forces analysis, SWOT analysis, feasibility study, and investment return breakdown and used to analyze the growth of key vendors in the market. Moreover, the report presents a 360-degree overview of the competitive.

Enquire Before Buying : https://www.globalmarketers.biz/report/life-sciences/global-animal-stem-cell-therapy-market-2019-by-manufacturers,-regions,-type-and-application,-forecast-to-2024/130268#inquiry_before_buying

Influence of the Animal Stem Cell Therapy Market report:

Animal Stem Cell Therapy MarketReport:

The Animal Stem Cell Therapy Market Report Addresses the Following Queries:

Table of Contents: Animal Stem Cell Therapy Market

Chapter 1: Overview of Animal Stem Cell Therapy Market

Chapter 2:Global Market Status and Forecast by Regions, Type

Chapter 3:Global Animal Stem Cell Therapy Market Status and Forecast by Downstream Industry

Chapter 5:Market Driving Factor Analysis

Chapter 6:Market Competition Status by Major Key Vendors

Chapter 7:Upstream and Downstream Animal Stem Cell Therapy Market Analysis

Chapter 8:Cost and Gross Margin Analysis

Chapter 9:Marketing Status Analysis

Chapter 10:Animal Stem Cell Therapy Market Report Conclusion

For more Information or Browse the complete report @ https://www.globalmarketers.biz/report/life-sciences/global-animal-stem-cell-therapy-market-2019-by-manufacturers,-regions,-type-and-application,-forecast-to-2024/130268#table_of_contents

Read more:
Global Animal Stem Cell Therapy Market Report 2020 By Key Players, Trends, Countries, Market Size, Forecast To 2024 (based On 2020 Covid-19 Worldwide...

The US is deporting scientists. I’m one of them – Massive Science

Some 8.7 million years ago, much of what is now Idaho was torched by clouds of hot volcanic ash, destroying all vegetation and animals in sight. The supervolcano, Yellowstone, was erupting. This was Yellowstones largest eruption on record.

Super-eruptions can decimate entire regions, and their cocktail of ash and gases can alter the climate.But, even though they eject huge amounts of material, there are very few documented super-eruptions in the geologic record. So we dont fully understand why they are so big or how often they occur. Now, details of the Yellowstone supervolcanic eruption are documented in a new study published in the journal Geology.

Yellowstones ancient eruptions scattered volcanic debris across the northwestern US. There are so many deposits covering an area tens of thousands of square kilometers that it can be difficult to tell each eruption apart. To get around this, volcanologists collected detailed identifying information, including chemical and chronological data, on each geological deposit.

Volcanic ash from Yellowstone

Wikimedia

When they looked at the data, they found that much of the volcanic debris, which was thought previously to come from repeated smaller eruptions, had the same chemical makeup and age. In fact, these deposits were produced by two previously unrecognized super-eruptions. Both eruptions were searingly hot, and would have baked the landscape in a thick coating of molten volcanic glass. The youngest of the two, known as the Greys Landing super-eruption, is dated to roughly 8.7 million years ago, and, according to the volume of debris released, is 30% larger than all other eruptions recorded from Yellowstone.

Recognition of these events brings Yellowstone's total number of eruptions during the late Miocene to six. That makes for one eruption about every 520,000 years. Since then, however, the pace of eruptions has slowed to once every 1.5 million years.

The evidence seems to suggest that Yellowstone is slowing down. And if this trend continues, the next super-eruption won't happen for another 900,000 years. Predicting eruptions is however a risky business, and the United States Geological Survey still maintain a permanent monitoring network on Yellowstone just in case.

Go here to see the original:
The US is deporting scientists. I'm one of them - Massive Science

Canine Stem Cell Therapy Market-Segmentation And Analysis By Recent Trends, Top 4 Manufactures -VETSTEM BIOPHARMA, Cell Therapy Sciences, Regeneus,…

Canine Stem Cell Therapy Marketreport provides in-depth COVID19 impact analysis ofMarket Overview, Product Scope, Market Drivers, Trends, Opportunities,Market Driving Force and Market Risks. It also profile the topmost prime manufacturers (VETSTEM BIOPHARMA, Cell Therapy Sciences, Regeneus, Aratana Therapeutics, Medivet Biologics, Okyanos, Vetbiologics, VetMatrix, Magellan Stem Cells, ANIMAL CELL THERAPIES, Stemcellvet) are analyzed emphatically by competitive landscape contrast, with respect toPrice, Sales,Capacity, Import, Export, Consumption, Gross, Gross Margin, Revenue and Market Share. Canine Stem Cell Therapy industry breakdown data are shown at the regional level, to show the sales, revenue and growth by regions.Canine Stem Cell Therapy Market describe Canine Stem Cell Therapy Sales Channel,Distributors, Customers, Research Findings and Conclusion, Appendix and Data Source.

Key Target Audience of Canine Stem Cell Therapy Market:Manufacturers of Canine Stem Cell Therapy, Raw material suppliers, Market research and consulting firms, Government bodies such as regulating authorities and policy makers, Organizations, forums and alliances related to Canine Stem Cell Therapy market.

Get Free Sample PDF (including full TOC, Tables and Figures)of Canine Stem Cell Therapy[emailprotected]https://www.researchmoz.us/enquiry.php?type=S&repid=2081893

In-Depth Qualitative Analyses Include Identification and Investigation Of The Following Aspects:Canine Stem Cell Therapy Market Structure, Growth Drivers, Restraints and Challenges, Emerging Product Trends & Market Opportunities, Porters Fiver Forces.

Summary of Canine Stem Cell Therapy Market:The non-invasive stem cell obtaining procedure, augmented possibility of accomplishing high quality cells, and lower price of therapy coupled with high success rate of positive outcomes have collectively made allogeneic stem cell therapy a preference for veterinary physicians. Moreover, allogeneic stem cell therapy is 100% safe, which further supports its demand on a global level. Pet owners are identified to prefer allogeneic stem cell therapy over autologous therapy, attributed to its relatively lower costs and comparative ease of the entire procedure.

A rapidly multiplying geriatric population; increasing prevalence of chronic ailments such as cancer and cardiac disease; growing awareness among patients; and heavy investments in clinical innovation are just some of the factors that are impacting the performance of the global healthcare industry.

On the basis on the end users/applications,this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Canine Stem Cell Therapy market foreach application, including-

Veterinary Hospitals Veterinary Clinics Veterinary Research Institutes

On the basis of product,this report displays the sales volume, revenue (Million USD), product price, market share and growth rate ofeach type, primarily split into-

Allogeneic Stem Cells Autologous Stem cells

Do You Have Any Query Or Specific Requirement? Ask to Our Industry[emailprotected]https://www.researchmoz.us/enquiry.php?type=E&repid=2081893

Important Canine Stem Cell Therapy Market Data Available In This Report:

Contact:

ResearchMozMr. Rohit Bhisey,Tel: +1-518-621-2074USA-Canada Toll Free: 866-997-4948Email:[emailprotected]

Browse More Reports Visit @https://bit.ly/2Sepby2

Excerpt from:
Canine Stem Cell Therapy Market-Segmentation And Analysis By Recent Trends, Top 4 Manufactures -VETSTEM BIOPHARMA, Cell Therapy Sciences, Regeneus,...

Covid-19 Impact on Canine Stem Cell Therapy Market in 2026 Trends Analysis, Top Manufacturers, Shares, Growth Opportunities, Statistics – Owned

Persistence Market Research (PMR) has published a new research report on canine stem cell therapy. The report has been titled, Canine Stem Cell Therapy Market: Global Industry Analysis 2016 and Forecast 20172026.Veterinary research has been used in regenerative and adult stem cell therapy andhas gained significant traction over the last decade.

Canine stem cell therapy products are identified to have gained prominence over the past five years, and according to the aforementioned research report, the market for canine stem cell therapy will expand at a moderate pace over the next few years.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/15550

Company Profiles

Key Questions Answered in Market Report:

Though all animal stem cells are not approved by FDA, veterinary stem-cell manufacturers and university researchers have been adopting various strategies in order to meet regulatory approvals, and streamline and expedite the review-and-approval process. The vendors in the market are incessantly concentrating on research and development to come up with advanced therapy, in addition to acquiring patents.

In September 2017, VetStem Biopharma, Inc. received European patent granted to the University of Pittsburgh and VetStem received full license of the patent then. This patent will eventually provide the coverage for the ongoing commercial and product development programs of VetStem and might be also available for licensing to other companies who are rather interested in this field.

The other companies operating in the global market for canine stem cell therapy are VETherapy Corporation, Aratana Therapeutics, Inc., Regeneus Ltd, Magellan Stem Cells, Animal Cell Therapies, Inc., and Medrego, among others.

According to the Persistence Market Research report, the globalcanine stem cell therapy marketis expected to witness a CAGR of 4.2% during the forecast period 2017-2026. In 2017, the market was valued at US$ 151.4 Mn and is expected to rise to a valuation of US$ 218.2 Mn by the end of 2026.

Burgeoning Prevalence of Chronic Diseases in Dogs to Benefit Market

Adipose Stem Cells (ASCs) are the most prevalent and in-demand adult stem cells owing to their safety profile, ease of harvest, and use and the ability to distinguish into multiple cell lineages. Most early clinical research is focused on adipose stem cells to treat various chronic diseases such as arthritis, tendonitis, lameness, and atopic dermatitis in dogs.

A large area of focus in veterinary medicine is treatment of osteoarthritis in dogs, which becomes more prevalent with age. Globally, more than 20% dogs are suffering from arthritis, which is a common form of canine joint and musculoskeletal disease. Out of those 20%, merely 5% seem to receive the treatment.

However, elbow dysplasia in canine registered a prevalence rate of 64%, converting it into an alarming disease condition to be treated on priority. Thereby, with the growing chronic disorders in canine, the demand for stem cell therapy is increasing at a significant pace.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/15550

Expensive Nature of Therapy to Obstruct Growth Trajectory

Expensive nature and limited access to canine stem cell therapy has demonstrated to be a chief hindrance forestalling its widespread adoption. The average tier II and tier III veterinary hospitals lack the facilities and expertise to perform stem cell procedures, which necessitates the referral to a specialty vet hospital with expertise veterinarians.

A trained veterinary physician charges high treatment cost associated with stem cell therapy for dogs. Generally, dog owners have pet insurance that typically covers maximum cost associated with steam cell therapy to treat the initial injury but for the succeeding measures in case of retreatment, the costs are not covered under the pet insurance. The stem cell therapy is thus cost-prohibitive for a large number of pet owners, which highlights a major restraint to the market growth. Stem cell therapy is still in its developmental stage and a positive growth outcome for the market cannot be confirmed yet.

Excerpt from:
Covid-19 Impact on Canine Stem Cell Therapy Market in 2026 Trends Analysis, Top Manufacturers, Shares, Growth Opportunities, Statistics - Owned

Canine Stem Cell Therapy Market 2020-2026: Analysed By Business Growth, Development Factors, Applications, And Future Prospects – 3rd Watch News

Canine Stem Cell Therapy Market report provides (6 Year Forecast 2020-2026) including detailed Coronavirus (COVID-19) impact analysis on Market Size, Regional and Country-Level Market Size, Segmentation Market Growth, Market Share, Competitive Landscape, Sales Analysis and Value Chain Optimization. This Canine Stem Cell Therapy market competitive landscape offers details by topmost key manufactures (VETSTEM BIOPHARMA, Cell Therapy Sciences, Regeneus, Aratana Therapeutics, Medivet Biologics, Okyanos, Vetbiologics, VetMatrix, Magellan Stem Cells, ANIMAL CELL THERAPIES, Stemcellvet) including Company Overview, Company Total Revenue (Financials), Market Potential, Presence, Canine Stem Cell Therapy industry Sales and Revenue Generated, Market Share, Price, Production Sites and Facilities, SWOT Analysis, Product Launch. For the period 2014-2020, this study provides the Canine Stem Cell Therapy sales, revenue and market share for each player covered in this report.

Key Target Audience of Canine Stem Cell Therapy Market: Manufacturers of Canine Stem Cell Therapy, Raw material suppliers, Market research and consulting firms, Government bodies such as regulating authorities and policy makers, Organizations, forums and alliances related to Canine Stem Cell Therapy market.

Get Free Sample PDF (including COVID-19 Impact Analysis, full TOC, Tables and Figures)of Canine Stem Cell Therapy[emailprotected]https://www.researchmoz.us/enquiry.php?type=S&repid=2081893

Synopsis of Canine Stem Cell Therapy Market:The non-invasive stem cell obtaining procedure, augmented possibility of accomplishing high quality cells, and lower price of therapy coupled with high success rate of positive outcomes have collectively made allogeneic stem cell therapy a preference for veterinary physicians. Moreover, allogeneic stem cell therapy is 100% safe, which further supports its demand on a global level. Pet owners are identified to prefer allogeneic stem cell therapy over autologous therapy, attributed to its relatively lower costs and comparative ease of the entire procedure.

A rapidly multiplying geriatric population; increasing prevalence of chronic ailments such as cancer and cardiac disease; growing awareness among patients; and heavy investments in clinical innovation are just some of the factors that are impacting the performance of the global healthcare industry.

Based onProduct Type, Canine Stem Cell Therapy market report displays the manufacture, profits, value, and market segment and growth rate of each type, covers:

Allogeneic Stem Cells Autologous Stem cells

Based onend users/applications, Canine Stem Cell Therapy market report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, this can be divided into:

Veterinary Hospitals Veterinary Clinics Veterinary Research Institutes

Canine Stem Cell Therapy Market: Regional analysis includes:

Do You Have Any Query Or Specific Requirement? Ask to Our Industry[emailprotected]https://www.researchmoz.us/enquiry.php?type=E&repid=2081893

The Canine Stem Cell Therapy Market Report Can Answer The Following Questions:

What are the Upstream Raw Materials And Manufacturing Equipment of Canine Stem Cell Therapy? What is the manufacturing process of Canine Stem Cell Therapy?

Who are the key manufacturers of Canine Stem Cell Therapy market? How are their operating situation (Capacity, Production, Price, Cost, Gross and Revenue)?

Economic impact on Canine Stem Cell Therapy industry and development trend of Canine Stem Cell Therapy industry.

What is the (North America, South America, Europe, Africa, Middle East, Asia, China, Japan) Production, Production Value, Consumption, Consumption Value, Import And Export of Canine Stem Cell Therapy?

What will the Canine Stem Cell Therapy Market Size and The Growth Rate be in 2026?

What are the key market trends impacting the growth of the Canine Stem Cell Therapy market?

What are the Canine Stem Cell Therapy Market Challenges to market growth?

What are the types and applications of Canine Stem Cell Therapy? What is the market share of each type and application?

What are the key factors driving the Canine Stem Cell Therapy market?

What are the Canine Stem Cell Therapy market opportunities and threats faced by the vendors in the Canine Stem Cell Therapy market?

Contact:

ResearchMozMr. Rohit Bhisey,Tel: +1-518-621-2074USA-Canada Toll Free: 866-997-4948Email:[emailprotected]

Browse More Reports Visit @https://www.mytradeinsight.blogspot.com/

Continued here:
Canine Stem Cell Therapy Market 2020-2026: Analysed By Business Growth, Development Factors, Applications, And Future Prospects - 3rd Watch News

Mishandling of the Covid-19 pandemic raises concern, Asia News & Top Stories – straits times

Misleading claims of Covid-19 cure

Vincentius Aji Jatikusumo

The Jakarta Post, Indonesia

Researchers at Airlangga University (Unair) and the State Intelligence Agency (BIN) released on June 12 what appeared to be an encouraging statement: the discovery of five combination drug therapies and two stem cell therapies for treating Covid-19.

The joint statement also said that the medicines were ready for distribution to treat Covid-19 patients.

In theory, the drug combinations recommended by Unair and BIN have the potential to inhibit Sars-CoV-2. However, none of the recommended drugs have been proved in any clinical study to be a safe and effective treatment for Covid-19.

In fact, evidence exists that one of the drugs, hydroxychloroquine, may worsen the condition of patients. This led the World Health Organisation to suspend the clinical trial of the drug.

Unair and BIN are correct in conducting in vitro (test tube) experiments to verify the effect and toxicity of the drugs. Unfortunately, they have not communicated in any clear way on how they designed, executed and analysed their experiments.

Stem cell therapy is another Covid-19 treatment that Unair and BIN researchers have proposed.

However, stem cell therapy is still considered very risky, expensive and limited to treating a few cancers, such as leukaemia. No evidence exists that stem cell therapy is efficient in treating viral infections in the human body such as the coronavirus.

Unair's and BIN's valiant efforts should still be applauded, as they are committed to treating Covid-19 and ending the pandemic. However, everyone should realise that discovering treatments and developing a potential vaccine for a disease that was virtually unknown six months ago take a lot of time and resources.

Unair and BIN said that they had submitted their research to at least seven peer-reviewed international journals, but this does not mean that their research is validated immediately. It still needs to be reviewed and questioned by their scientific peers.

A policeman standing guard at a barricade at a restricted area sealed by the authorities in Lahore, Pakistan, last Thursday. It is evident that, much like the global trend in countries where Covid-19 cases have soared, Pakistan's daily cases and deaths are growing, says one of the writers. PHOTO: AGENCE FRANCE-PRESSE

Michael Tan

Philippine Daily Inquirer, The Philippines

We are truly fortunate that, in the Philippines, we have adopted masks wholeheartedly, although with some lapses in the way they are used.

We are all right with masks, but with testing, we are pretty much like the United States, with all the well-publicised criticism of our testing continuing to be haphazard and without a sense of direction.

I have written about this several times, as has my fellow columnist Mahar Mangahas: We need random testing or, to use an epidemiological term, sentinel surveillance - looking at all geographical areas and at different population groups, and not just the so-called high-risk ones.

Random (but systematic) testing is not mass testing. We do not need to test all 110 million Filipinos, but we do need to have representative geographical distribution so we can have early detection. Right now, we wait for an outbreak and then rush in to test, and we are often by then overwhelmed by the speed of its spread, as is happening now in Cebu.

What I worry about now is that even while we are improving, ever so slowly, on testing, we do not seem to be doing adequate contact tracing, which must go together with the testing. Contact tracers look at the people behind the numbers. It is through contact tracing that we have obtained some of the very important information on superspreader venues.

Editorial

The Yomiuri Shimbun, Japan

The spread of infections with the coronavirus has directly hit the vulnerabilities in Japan's politics, economy and society. The country must make all-out efforts to restore peace of mind to people's lives.

The Yomiuri Shimbun has compiled a set of proposals to build a society that is resistant to infectious diseases in preparation for the arrival of a second wave of infections.

First, the proposal calls for improving the PCR (polymerase chain reaction) testing system and increasing the number of tests to 100,000 a day. By combining it with antigen tests and other methods appropriately, it is hoped that the reality of the infection situation will be revealed.

A shortage of hospital beds must be avoided. Place people with mild symptoms in accommodation facilities, hospitalise those with moderate symptoms in priority medical institutions and those with severe symptoms in advanced medical institutions.

To increase the speed of implementing measures and delivering clear messages, the creation of a control tower initiated by the prime minister to lead infectious disease measures will be effective.

Second, as for economic stimulus measures, it has taken time to provide cash relief and loans. Efforts must be accelerated to restructure the relevant systems.

There is no point in compiling a budget unless funds are actually distributed. The government must thoroughly reflect on the situation and establish an infrastructure that enables swift budget execution.

Another task is to accelerate digitalisation, which lags behind other countries. Online handling of applications needs to be strengthened, so that people can receive benefits and loans through simple procedures.

Third, international cooperation will be essential to the development of vaccines and therapeutic drugs and the distribution of them. It is proper for Japan, as the host country preparing for the Tokyo Olympics and Paralympics, to take the lead.

Badiuzzaman Bay

The Daily Star, Bangladesh

According to a tell-all report by The Daily Star, a number of professional bodies have secured beds for their members and families at several private hospitals in Dhaka.

On June 11, the Bangladesh Judicial Service Association signed a deal with the Universal Medical College Hospital to provide treatment to lower court judges suffering from Covid-19 and other diseases.

Not to be outdone, the Bangladesh Police on May 5 "hired" an entire hospital (Impulse Hospital) for 2 months to treat its members.

Since when has it been it all right to "book" entire hospitals or hospital beds for certain people? Should we accept this as a new normal where access to treatment for the common people will be contingent on the availability of beds left by the influential?

Since March 8, when the country confirmed its first coronavirus case, there have been multiple reports of ordinary people desperately moving from one hospital to another without receiving treatment. Recently, the nurse of a private hospital in Dhaka died after being denied treatment by the very hospital she worked at.

A common thread running through these heartbreaking episodes is the victims' "ordinariness", their having no power or connections that could qualify them for treatment.

The situation has reached a point where people are simply afraid to have anything to do with sickness lest they need to confront the challenges of hospitalisation.

Editorial

Dawn, Pakistan

On multiple days since the middle of this month, official figures for coronavirus-related deaths in the country have been well over 100. According to press releases issued by the National Command and Operation Centre, 111 people lost their lives to Covid-19 on June 16 and 136 on June 17.

About a week ago, the official death toll in a single day was 153 - the highest in 24 hours since the start of the outbreak in Pakistan at the end of February. As these figures continue to climb, the daily number of tests towards the end of this month stands at an average of 28,500 - far lower than the 100,000 daily testing milestone the government has calculated for next month.

It is evident that, much like the global trend in countries where Covid-19 cases have soared, Pakistan's daily cases and deaths are growing.

Although the authorities may argue that cases and deaths here are still lower than in many of the worst-hit countries, the reality is that Pakistan is still over a month away from what the authorities and think-tanks have estimated to be the "peak phase".

As we approach that dreaded period, testing must be ramped up, and fast, so that we can have a realistic picture of the spread of Covid-19.

The View From Asia is a compilation of articles from The Straits Times' media partner Asia News Network, a grouping of 24 news media titles.

Read this article:
Mishandling of the Covid-19 pandemic raises concern, Asia News & Top Stories - straits times

Top 10 Best Cream Serum With Vitamin Es 2020 – Best gaming pro

As advertisers draw back from Facebook to protest the social networking larges hands-off strategy to misinformation and hate speech, the corporate is instituting a variety of stronger insurance policies to woo them again.

In a livestreamed section of the corporates weekly all-hands assembly, CEO Mark Zuckerberg recapped among the steps Fb is already taking, and introduced new measures to battle voter suppression and misinformation though they quantity to issues that different social media platforms like Twitter have already enahatected and enforced in additional aggressive methods.

On the coronary heart of the coverage adjustments is an admission that the corporate will proceed to permit politicians and public figures to disseminate hate speech that does, in truth, violate Fbs personal tips however its going to add a label to indicate theyre remaining on the platform due to their newsworthy nature.

Its a watered-down model of the extra muscular stance that Twitter has taken to restrict the flexibility of its community to amplify hate speech or statements that incite violence.

Zuckerberg said:

A handful of occasions a yr, we depart up content material that will in any other case violate our insurance policies if the general public curiosity worth outweighs the danger of hurt. Usually, seeing speech from politicians is within the public curiosity, and in the identical means that information shops will report what a politician says, we predict folks ought to typically have the ability to see it for themselves on our platforms.

Well quickly begin labeling among the content material we depart up as a result of its deemed newsworthy, so folks can know when that is the case. Well permit folks to share this content material to sentence it, similar to we do with different problematic content material, as a result of this is a vital a part of how we talk about whats acceptable in our society however well add a immediate to inform those that the content material theyre sharing might violate our insurance policies.

The issues with this strategy are legion. Finally, its one other instance of Fbs insistence that with hate speech and different sorts of rhetoric and propaganda, the onus of accountability is on the consumer.

Zuckerberg did emphasize that threats of violence or voter suppression are usually not allowed to be distributed on the platform whether or not or not theyre deemed newsworthy, including that there are not any exceptions for politicians in any of the insurance policies Im saying right here in the present day.

Nevertheless it stays to be seen how Fb will outline the character of these threats and steadiness that in opposition to the newsworthiness of the assertion.

The steps round election yr violence complement different efforts that the corporate has taken to fight the unfold of misinformation round voting rights on the platform.

The brand new measures that Zuckerberg introduced additionally embrace partnerships with native election authorities to find out the accuracy of knowledge and whats doubtlessly harmful. Zuckerberg additionally stated that Fb would ban posts that make false claims (like saying ICE brokers will likely be checking immigration papers at polling locations) or threats of voter interference (like My pals and I will likely be doing our personal monitoring of the polls).

Fb can also be going to take further steps to limit hate speech in promoting.

Particularly, were increasing our adverts coverage to ban claims that folks from a particular race, ethnicity, nationwide origin, non secular affiliation, caste, sexual orientation, gender identification or immigration standing are a menace to the bodily security, well being or survival of others, Zuckerberg stated. Were additionally increasing our insurance policies to higher defend immigrants, migrants, refugees and asylum seekers from adverts suggesting these teams are inferior or expressing contempt, dismissal or disgust directed at them.

Zuckerbergs remarks got here days of advertisers most not too long ago Unilever and Verizon introduced that theyre going to tug their cash from Fb as half the #StopHateforProfit marketing campaign organized by civil rights teams.

These are small, good steps from the top of a social community that has been recalcitrant within the face of criticism from all corners (besides, till now. from the advertisers that matter most to Fb). However they dont do something in any respect in regards to the teeming mass of misinformation that exists within the non-public channels that simmer beneath the floor of Fbs public going through messages, memes and commentary.

See the rest here:
Top 10 Best Cream Serum With Vitamin Es 2020 - Best gaming pro

In the middle of a pandemic, a young Minnesota mother fights her second cancer diagnosis – Minneapolis Star Tribune

By and photos by alex kormann Star Tribune

June 26, 2020 5:10pm

Taylor Bustos rubbed her newly shaved head in the dimly lit basement of her temporary Rochester home as an intrepid thought seized her. This better freaking be the last time.

Two years ago, Bustos was happy. She was 20, recently married and had just found out she was pregnant with her first child. Taylor and her husband, Mark, 21, envisioned moving from Duluth to California and raising half a dozen kids. But those plans would have to wait.

Five months into her pregnancy, Bustos felt a lump on her neck. On Oct. 5, 2018, just a month after giving birth to her son, Solomon, she was diagnosed with nodular sclerosis classical Hodgkins lymphoma. Its the most common type of Hodgkins lymphoma, a cancer that affects the bodys immune system.

I was told, This is the good cancer, its curable, Bustos said. She underwent six months of chemotherapy at St. Lukes Radiation Oncology Associates in Duluth and was declared in remission in April 2019. After that, life went pretty much back to normal.

But last November, just before her first follow-up PET CT scan, Bustos prepared for the worst. A few weeks earlier, she had felt the lump in her neck return.

Soon later, she was back at St. Lukes, prepared to receive whatever news may come. Mark tossed a bright pink ball to Solomon to distract the boy and himself from the mounting anxiety as they waited for what felt like an eternity in the small examination room.

The young father was also trying to manage his stress from recently learning he was being laid off from his construction job. The doctor finally stepped in.

Taylor Bustos got a follow-up PET CT scan in her first follow-up scan since being declared cancer free six months earlier. It was not good news. More chemotherapy. She slept through most of her treatments as the potent drugs worked to rid her body of cancer. When Taylors hair started to fall out in clumps, Mark shaved her head. But again, her family didnt let her do this alone.

Im sitting there with a one-year-old and my husband of two years and theyre telling me at 22 years old that I have cancer for the second time, Bustos said.

She had gone into the meeting with the mind-set that she would never endure chemotherapy again. It was physically and mentally unlike any other suffering Ive ever gone through in my life and I didnt want to willingly say yes to going back there, Bustos said.

After a week of thinking and praying, Bustos stumbled across a Facebook post from a friend who had recently lost his father in a house fire. His words resonated so deeply with her that she decided she couldnt just lay down and die. This cancer could kill me, but dont I want my sweet son to know I tried? she said.

Once again, she went in for treatments, then slept for three days. The big difference this time was that, to make sure the cancer never came back, she was going to have to follow the doctors next recommendation.

On March 2, the Bustos family picked up and moved 200 miles across the state to Rochester for three months where she would undergo some of the most toxic chemotherapy available at the Mayo Clinic. The mix was so potent that she had to first undergo a stem cell collection; those stem cells would be transplanted afterward to regrow her immune system and other healthy cells decimated by the chemo.

Marks layoff, which at first seemed like a disaster, was now a gift. He could assume a larger role as the family caretaker. Some people might call that luck, but the Bustoss dont believe in luck. For them, it was an act of God.

When it came time to move, Taylors parents, Pam and Jerry, who live across the street from the Bustoses in Duluth, moved with them to help take care of Solomon and Taylor.

It really wasnt a difficult decision, said Jerry, who is a warehouse operator at a Duluth paper supply business.

For me, he said, I would do whatever it takes to get her healthy.

Above left, Taylor entered Mayo Clinic for a week of continuous chemotherapy treatment in the middle of the COVID-19 pandemic. When she got home, cuddles from son Solomon and sleeping in her own bed were two longed-for moments.

Their family squeezed as much as they could into their two cars, boxes stacked to the roof, rendering the rearview mirror useless. The family settled into a small house only a mile away from the Mayo Clinic.

Just over a week later, COVID-19 hit.

We knew Id have a weakened immune system and wed have to quarantine, Bustos said, but suddenly the whole world had to quarantine, too.

They stayed closely connected with their church through video chat and live streams. In solidarity, her entire family shaved their heads along with Bustos.

A little over a month after moving, Bustos prepared for her most difficult round of chemotherapy. All the effects of normal chemo, including nausea, exhaustion, loss of appetite and body pain would be amplified. And because of the coronavirus, she would be doing it alone. She packed her keyboard piano, a weeks worth of clothes, a few mementos from home and headed to the hospital. She would have to stay in a heavily filtered room by herself for a full week as she underwent treatment.

Masked nurses came and went as Bustos tried to picture what they looked like under all the PPE. Most days, she felt immensely lonely and sad. Originally, she was told shed be able to go home to see her family for one hour per day. The pandemic scrapped those plans. I would cry and nurses couldnt put their hand on my shoulder to tell me, Its OK, because of the coronavirus, Bustos said.

When she was finally able to return to her family a full week later, Bustos was ecstatic. To be able to be hugged was a very welcome relief from despair, she said.

She began to try and process what had happened to her over the last five months. She felt distant from and misunderstood by nearly everyone around her. It can look like its going well from the outside but when you literally want to die, the emotional side of things needs to be handled, she said.

Bustos has since begun therapy and is taking anti-depressants to help manage her mental pain.

As the family moved out of Rochester, the snow was gone. Birds chirped and flowers bloomed; a sign of rebirth and a new beginning.

When they pulled up in front of their apartment in Duluth, chalk drawings graced their sidewalk welcoming them home. Their front door was covered in balloons and a welcome banner was strung across the door frame, all put together by members of Bustoss church youth group.

Bustos collapsed on her old bed. She thought shed feel different in their own apartment, but it oddly felt the same. She had come to realize that home was no longer a physical space. Cancer changed that.

Home for me has become Mark and Solomon, she said, and so whether were in Rochester, Duluth or Timbuktu, Im home when Im with them.

Alex Kormann on Instagram: @alexkormann12

Excerpt from:
In the middle of a pandemic, a young Minnesota mother fights her second cancer diagnosis - Minneapolis Star Tribune

WEATHER NOW: Warm Less Humid Thursday – WPRI.com

Outgoing Bryant president: Retirement will include plenty of paintingVideo / 7 hours ago

12 on 12 Digital Original: Perspectives on Race - debuts Tuesday at 5 p.m.Video / 14 hours ago

Perspectives on Race: A 12 on 12 Digital Original Debuts Tuesday at 5Video / 9 hours ago

New hotel opens in Newport as tourism industry picks back upVideo / 7 hours ago

Woman's body found in Providence; murder investigation underwayVideo / 3 hours ago

VIDEO NOW: Massachusetts Governor Baker on COVID-19; $275 million package to promote equityVideo / 11 hours ago

Pawtucket to hand out free medical masks to residents, businesses SaturdayVideo / 7 hours ago

Woonsocket man charged with shooting, killing roommateVideo / 7 hours ago

VIDEO NOW: Wooonsocket Police Chief Thomas Oates discusses homicide investigation on Cass AvenueVideo / 11 hours ago

Hospitalizations below 100 for first time since March; first RI child contracts rare syndromeVideo / 7 hours ago

VIDEO NOW: Dr. Alexander-Scott on RI's first confirmed case of multisystem inflammatory syndrome and situation at RI Vets homeVideo / 11 hours ago

VIDEO NOW: Governor Raimondo on COVID-19 data, following the rules, and childhood immunizationsVideo / 11 hours ago

Go here to see the original:
WEATHER NOW: Warm Less Humid Thursday - WPRI.com

Back to Top